Summit Therapeutics (SMMT) Q2 2026 Earnings

Apr 30Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.76
-0.54
-0.31
-0.09

Details

Expected EPS
-0.269222
Actual EPS
-0.24
Surprise EPS
0.03
Surprise Percent
+10.85%

Description

⁨Summit Therapeutics⁩ (⁦SMMT⁩) has reported earnings of ⁦-0.24⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts